Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 75,000 shares at $52.65 ($3.9M) on 2023-12-19, disclosed to the SEC on 2023-12-19.
Scheduled sale ($3.9M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.44 | 11,974 | $628K | 15.9% |
| 2 | $52.44 | 11,974 | $628K | 15.9% |
| 3 | $52.44 | 13,026 | $683K | 17.3% |
| 4 | $52.44 | 13,026 | $683K | 17.3% |
| 5 | $52.65 | 25,000 | $1.3M | 33.4% |
| Total | $52.51 avg | 75,000 |
| $3.9M |
| 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |